Por un escritor de hombre misterioso
Download scientific diagram | Natural EVs in cancer therapy. a) TEX stimulate immune activation by boosting T‐cell expansion and function via APCs especially DC cells. DEX activate T cells by mimicking the role of APCs. b) NK‐cell‐derived EVs induce tumor cell death through FasL, perforin, and TNF‐α. c) EVs from M1 macrophages can re‐educate tumor associated macrophages from M2 to M1 phenotype, which further activates anti‐tumor immunity. d) Stem‐cell‐derived EVs inhibit the growth of tumor cells through miRNA‐mediated mechanisms. Abbreviations: DC cell, dendritic cell; DEX, dendritic cell‐derived EVs; FasL, Fas ligand; M1 EVs, M1 macrophage‐derived EVs; MHC, major histocompatibility complex; MSCs, mesenchymal stem cells; NK EVs, NK cell‐derived EVs; TCR, T cell receptor; TEX, tumor cell‐derived EVs; TNF‐α, tumor necrosis factor‐α; TNFR, tumor necrosis factor receptor. from publication: Engineered Extracellular Vesicles for Cancer Therapy | Extracellular vesicles (EVs) have emerged as a novel cell-free strategy for the treatment of many diseases including cancer. As a result of their natural properties to mediate cell-to-cell communication and their high physiochemical stability and biocompatibility, EVs are | Extracellular Vesicles, Cancer Therapy and Bioinspired | ResearchGate, the professional network for scientists.
The roles of extracellular vesicles in the immune system
Antiviral CD8+ T-cell immune responses are impaired by cigarette smoke and in COPD
Tumor-derived extracellular vesicles in melanoma immune response and immunotherapy - ScienceDirect
CD137: An Important Target in T Cell Co-Stimulation
Engineered extracellular vesicles: potentials in cancer combination therapy, Journal of Nanobiotechnology
Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
Frontiers Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma
Cancers, Free Full-Text
mRNA vaccine - Wikipedia
Natural EVs in cancer therapy. a) TEX stimulate immune activation by
Natural EVs in cancer therapy. a) TEX stimulate immune activation by
Extracellular vesicle–based drug delivery in cancer immunotherapy
Utilizing stem cells to support and aid cancer therapy
Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion
Extracellular vesicles in immunity – Research group Susanne Gabrielsson